Related Experiment Video
Updated: Jul 3, 2026

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Antibiotic prophylaxis for children with primary vesicoureteral reflux: where do we stand today?
Michiel Costers1, Rita Van Damme-Lombaerts, Elena Levtchenko
1Antibiotic Management Team, University Hospital Leuven Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. michiel.costers@uz.kuleuven.ac.be
Insights
Antibiotic prophylaxis for pediatric vesicoureteral reflux (VUR) may be safely discontinued in select children, as evidence suggests it offers no significant benefit over intermittent treatment for preventing recurrent urinary tract infections (UTIs) or kidney damage.
Area of Science:
- Pediatric Urology
- Nephrology
- Infectious Diseases
Background:
- Vesicoureteral reflux (VUR) management aims to prevent recurrent urinary tract infections (UTIs) and subsequent renal damage.
- Long-term antibiotic prophylaxis has been a standard practice for children with VUR since 1997.
- Uncertainty exists regarding the necessity and efficacy of continuous antibiotic prophylaxis.
Purpose of the Study:
- To systematically review the evidence on discontinuing antibiotic prophylaxis in children with VUR.
- To evaluate the effectiveness of antibiotic prophylaxis in preventing recurrent UTIs and renal damage.
- To identify patient subsets who may safely stop antibiotic prophylaxis.
Main Methods:
- Systematic review of existing literature.
- Inclusion of uncontrolled studies and recent randomized controlled trials (RCTs).
- Analysis focused on UTI recurrence and new renal damage rates.
Main Results:
- Uncontrolled studies suggest discontinuing prophylaxis is feasible for specific children (school-aged, low-grade VUR, normal anatomy, no hydronephrosis/scars).
- Recent RCTs indicate no significant advantage of continuous prophylaxis over intermittent antibiotic therapy for UTI prevention or renal damage.
- Evidence supports a potential shift in management strategies for VUR.
Conclusions:
- Antibiotic prophylaxis may be safely discontinued in carefully selected pediatric VUR patients.
- Intermittent antibiotic therapy appears as effective as continuous prophylaxis for preventing UTIs and renal damage.
- Current guidelines may need re-evaluation based on emerging evidence.
Abstract:
The main goal of the management of vesicoureteral reflux (VUR) is prevention of recurrent urinary tract infections (UTIs), and thereby prevention of renal parenchymal damage possibly ensuing from these infections. Long-term antibiotic prophylaxis is common practice in the management of children with VUR, as recommended in 1997 in the guidelines of the American Urological Association. We performed a systematic review to ascertain whether antibiotics can be safely discontinued in children with VUR and whether prophylaxis is effective in the prevention of recurrent UTIs and renal damage in these patients. Several uncontrolled studies indicate that antibiotic prophylaxis can be discontinued in a subset of patients, that is, school-aged children with low-grade VUR, normal voiding patterns, kidneys without hydronephrosis or scars, and normal anatomy of the urogenital system. Furthermore, a few recent randomized controlled trials suggest that antibiotic prophylaxis offers no advantage over intermittent antibiotic therapy of UTIs in terms of prevention of recurrent UTIs or new renal damage.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi III: Medical Management
Pharmacokinetics in Pediatric Patients: Drug Excretion